{"id":24783,"date":"2021-06-28T07:00:36","date_gmt":"2021-06-28T05:00:36","guid":{"rendered":"http:\/\/localhost:8888\/TG210808\/?p=24783"},"modified":"2026-07-09T15:57:08","modified_gmt":"2026-07-09T13:57:08","slug":"premier-patient-inclus-au-royaume-uni-dans-lessai-de-phase-i-de-tg4050-plateforme-myvac-limmunotherapie-individualisee-de-transgene","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/premier-patient-inclus-au-royaume-uni-dans-lessai-de-phase-i-de-tg4050-plateforme-myvac-limmunotherapie-individualisee-de-transgene\/","title":{"rendered":"Premier patient inclus au Royaume-Uni dans l\u2019essai de Phase I de TG4050 (plateforme myvac\u00ae), l\u2019immunoth\u00e9rapie individualis\u00e9e de Transgene"},"content":{"rendered":"\n<div title=\"cgTitle\">\u00a0<\/div>\n\n\n\n<p class=\"eplus-hfPF2V\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20210628-TG4050-1st-UK-patient-FR.pdf\">Premier patient inclus au Royaume-Uni dans l\u2019essai de Phase I de TG4050 (plateforme myvac\u00ae), l\u2019immunoth\u00e9rapie individualis\u00e9e de Transgene<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 Premier patient inclus au Royaume-Uni dans l\u2019essai de Phase I de TG4050 (plateforme myvac\u00ae), l\u2019immunoth\u00e9rapie individualis\u00e9e de Transgene<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[134,11,128,71,80],"tags":[],"class_list":["post-24783","post","type-post","status-publish","format-standard","hentry","category-134","category-press-release-fr","category-dates","category-myvac-fr","category-tg4050-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"nh","author_link":"https:\/\/www.transgene.com\/fr\/author\/nh\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 Premier patient inclus au Royaume-Uni dans l\u2019essai de Phase I de TG4050 (plateforme myvac\u00ae), l\u2019immunoth\u00e9rapie individualis\u00e9e de Transgene","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/24783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=24783"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/24783\/revisions"}],"predecessor-version":[{"id":41606,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/24783\/revisions\/41606"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=24783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=24783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=24783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}